Evaluation of agomelatine for the treatment of sleep problems in adults with autism spectrum disorder and co-morbid intellectual disability.

Pura BallesterMaría José MartínezMaría-Del-Mar IndaAuxiliadora JavaloyesAmanda L RichdaleJavier MurielCésar BeldaNatalia ToralDomingo MoralesEduardo FernándezAna María Peiró

Published in: Journal of psychopharmacology (Oxford, England) (2019)

Agomelatine was effective and well tolerated for treating insomnia and circadian rhythm sleep problems present in adults with ASD and ID.

Keyphrases

intellectual disability
autism spectrum disorder
sleep quality

mental health
physical activity
attention deficit hyperactivity disorder

bariatric surgery
atrial fibrillation

heart rate
combination therapy